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Abstract
Background: The aim of this experimental study on New Zealand's white rabbits was to find
differences in the results of treating the distal physeal femoral defect by the transplantation of
autologous or allogeneic mesenchymal stem cells (MSCs). After the excision of a created bone
b r i d g e  i n  t h e  d i s t a l  p h y s i s  o f  t h e  r i g h t  f e m u r ,  m o d i f i e d  c o m p o s i t e  s c a f f o l d  w i t h  M S C s  w a s
transplanted into the defect. In animal Group A (n = 11) autogenous MSCs were implanted; in
animal Group B (n = 15) allogeneic MSCs were implanted. An iatrogenic physeal defect of the left
femur of each animal not treated by MSCs transplantation served as control. The rabbits were
euthanized four months after the transplantation. The treatment results were evaluated
morphometrically (femoral length and valgus deformity measurement) and histologically (character
and quality of the new cartilage).
Results: Four months after the transplantation, the right femurs of the animals in Group A were
on average longer by 0.50 ± 0.04 cm (p = 0.018) than their left femurs, the right femurs of rabbits
in Group B were on average longer by 0.43 ± 0.01 cm (p = 0.028) than their left femurs.
4 months after the therapeutic transplantation of MSCs valgus deformity of the distal part of the
right femur of animals in Group A was significantly lower (by 4.45 ± 1.86°) than that of their left
femur (p = 0.028), in Group B as well (by 3.66 ± 0.95° than that of their left femur p = 0.001).
However, no significant difference was found between rabbits with transplanted autogenous MSCs
(Group A) and rabbits with transplanted allogeneic MSCs (Group B) either in the femur length (p
= 0.495), or in its valgus deformity (p = 0.1597). After the MSCs transplantation the presence of a
newly formed hyaline cartilage was demonstrated histologically in all the animals (both groups). The
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ability of transplanted MSCs to survive in the damaged physis was demonstrated in vivo by magnetic
resonance, in vitro by Perls reaction and immunofluorescence.
Conclusion: The transplantation of both autogenous and allogeneic MSCs into a defect of the
growth plate appears as an effective method of surgical treatment of physeal cartilage injury.
However, the Findings point to the conclusion that there is no clear difference in the final effect of
the transplantation procedure used.
Background
By impairment of enchondral ossification and normal
chondrogenesis in the area of growth cartilage of the long
bones of the extremities, a formation of the bone bridge
may occur with a subsequent disturbance of bone growth
[1,2]. For a number of years, rooted methods of treatment
of the physeal plate closure due to its trauma have been
passed on [3-5]. However, considering their exigence of
time and finances and the seriousness of possible compli-
cations, different procedures have been searched for in
experiments, that would allow correcting deformities (or
even to prevent the development of such deformities) of
the long bones of the extremities with an injured physis
less invasively and with a better clinical effect and lower
percentage of complications. Some departments have
started to focus their attention on transplantations of tis-
sues and cellular colonies into the defect with the aim to
restore physeal morphology and function. In the past six
years we have pursued experiments with the transplanta-
tion of chondrocytes and mesenchymal stem cells (MSCs)
into the damaged growth plate with the purpose to restore
its function (transplantation of autologous chondrocytes
into an iatrogenically injured growth plate of the distal
femur of the pig, prevention of formation of a bone bridge
by transplantation of allogeneic MSCs into an iatrogeni-
cally created defect, therapy of a formed bone bridge by its
excision and transplantation of allogeneic stem cells into
the created defect) [6-9]. Yet, in the area of cellular trans-
plantation a number of questions remain unanswered
before their possible clinical use in humans can happen.
One of these questions is also the aspects of autogenous
vs. allogeneic transplantations of mesenchymal stem cells
into the injured physeal growth zone of the extremity
bones.
The study of possible repair of the growth cartilage tissue
has notably benefited and advanced thanks to works
addressing the transplantation of autogenous chondro-
cytes into the growth cartilage defect [10-14]. In practice,
transplantation of autogenous chondrocytes represents
the collection of the cartilaginous tissue and subsequently
the cultivation of a chondrocyte graft that may be used for
the autogenous transplantation into a growth cartilage
defect after the lapse of approximately 3 weeks [15]. This
time lag between the autograft sampling and on possibil-
ity to implant cultivated cells might limit the autotrans-
plantation in actual clinical practice. Therefore, allograft
transplantation appears suitable in this regard, offering,
provided the availability of a tissue bank, the possibility of
immediate cell transplantation into the damaged target
tissue.
The aim of this experimental study focusing on the surgi-
cal treatment of an iatrogenically created bone bridge in
the distal physis of the femur in rabbits in form of its exci-
sion and subsequent transplantation of MSCs into the
physeal defect, was to find whether there would be differ-
ences between the results of treatment by transplantation
of autologous mesenchymal stem cells and by transplan-
tation of allogeneic MSCs, always in the same gel scaffold.
We evaluated the results of treatment partly on the basis
of measurements of the length and valgus deformity of
the femurs (morphometric variables of bone growth) and
partly with regard to the quality of the newly formed car-
tilaginous tissue at the site of the original physeal defect
(histological examination).
The proof that the newly formed chondrocytes at the site
of the original physeal defect originated from the trans-
planted mesenchymal stem cells was established partly in
vivo by demonstrating cells labelled with ferrous nano-
particles in the magnetic resonance examination and
partly in vitro using Pearls reaction and immunofluores-
cence.
Methods
The New Zealand white rabbit from a certified breeding
was chosen as the experimental animal. The experiment
included 26 healthy animals (12 males and 14 females) at
the age of 5 weeks at the bone marrow collection (at the
beginning of the experiment). The group of animals was
homogenous as regards weight (2.32 ± 0.14 kg). The rab-
bits were divided into two groups: Group A (therapeutic
autogenous transplantation of MSCs into the growth car-
tilage defect – 13 animals); and Group B (therapeutic all-
ogeneic transplantation of MSCs into the growth cartilage
defect – 13 animals). However, due to difficulties with
MSC cultivation (the autogenous graft did not reach the
needed number of cells on the day of transplantation) two
experimental animals from Group A had to be transferredBMC Biotechnology 2008, 8:70 http://www.biomedcentral.com/1472-6750/8/70
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to Group B. Thus, the final number of animals evaluated
in Group A was 11 and the final number of animals in
Group B was 15.
Preparation of the stem cells and the scaffold
Twenty one days before the transplantation of MSCs bone
marrow blood was collected in general anaesthesia from
the iliac wing on both sides. Using a punction needle (20
G/40 mm) an average of 2 ml blood was aspired from
tuber coxae alae osis illi in to the 5 mL syringe with 2 mL
Dulbecco's Phosphate Buffered Saline (PBS) with 2%
Fetal Bovine Serum (FBS, StemCell Technologies) and 5
IU heparin/mL connected with a hypodermic needle (20
G/40 mm). Under sterile conditions, the bone marrow
blood (about 4 mL) was deposited over 3 mL of Ficoll-
Paque PLUS (StemCell Technologies). After centrifuga-
tion at 400 g for 30 min at room temperature, the dense
gradient separated erythrocytes and granulocytes as a pel-
let in a bottom part of the tube; mononuclear cells were
situated in an opalescent layer between Ficoll and blood
plasma. This layer was taken out, washed in a culture
medium (see below) and used for propagation under in
vitro conditions. The average amount of mononuclear
cells from each isolation was 20 × 106 cells. Cell number
and viability was analyzed on Vi-CELL (Series Cell Viabil-
ity Analyzers) and about 90% of viable cells were
detected.
Cells were seeded in 75-cm2 tissue culture plastic flasks at
a density of approximately 5 × 105 cells/cm2 and cultured
at 37°C in humidified atmosphere with 5% of CO2. The
culture medium was α-MEM medium (Gibco) supple-
mented with 10% FBS (Sigma Aldrich) and gentamycin
(50 mg/mL, Sigma Aldrich). After 24 h of culture, the non-
adherent cells were removed and during the subsequent
culture (3 weeks) the medium was exchanged every third
day. The first colonies of mesenchymal stem cells
appeared after 4 to 5 days of culture and the 80% of con-
fluence was achieved after 10 days of culture. Cells were
passaged with trypsin 0.5% trypsin-EDTA solution (Sigma
Aldrich) for 5 min at 37°C and replated in 150 cm2 at a
density of 5000–6000 cells/cm2.
During the last three days of culture, cells were labeled
with nano-particles of iron oxide (Resovist, 0.5 mmol Fe/
mL, Schering). Resovist was added in concentration 1 μL/
mL culture medium. For labeling with a fluorescent dye
CM-DiI (Molecular Probes) in concentration 5 μg/2,5 mL
PBS, cells were harvested on day of transplantation, incu-
bated for 5 min at 37°C and for 15 min at 4°C. At the end
of labeling cells were thoroughly washed in PBS. To
induce chondrogenic differentiation [15], the labeled cells
were given in the differentiation medium composed of α-
MEM supplemented with 100 ng/mL recombinant
human TGF β1 (R&D Systems), 100 nM dexamethasone
(Medochemie), 50 μg/ml L-ascorbic acid 2-phosphate
(Sigma Aldrich), 1% insulin-transferrin-selenium A
(Gibco) for 30 min. Subsequently, the cells were centri-
fuged at 700 g for 5 min, and cell pellets were prepared for
their deposition in a scaffold.
The scaffolds were prepared in a 96 – well plate at about
4°C by mixing 20,75 μL of sodium hyaluronate (10 mg/
mL, 1500 kDa, kindly provided by CPN, CR) with 31,1 μL
of 1 mg/mL type I collagen in 0.1 M acetic acid (Collagen
type I from calf skin, acid soluble, Sigma), and neutralized
with 1 M KOH. Then a cell pellet (2 × 106 cells), resus-
pended in 36 μL of α-MEM was added. Subsequently, 120
μL of Tissucol solution in aprotinine (fibrinogen 70–110
mg/mL, aprotinine 3000 KIU/mL), and 120 μL of
thrombin solution (4 IU/mL) in CaCl2 (40 μmol/mL, Tis-
sucol® Kit, Baxter) were mixed and added to each well and
a content of each well was thoroughly mixed. The gel was
formed at 37°C for 15 min. Subsequently, the culture
medium was added and the scaffold was placed in an
incubator with a humidified atmosphere, 5% CO2 at
37°C and implanted on the same day.
Surgical procedures
Surgeries were performed under general anaesthesia.
Before anaesthesia, enrofloxacin (BAYTRIL 2.5% inj. ad
us. vet., Bayer) was administered intravenously at the dose
of 5 mg/kg. Induction was achieved by intramuscular
administration of midazolam (1.00 mg/kg (DORMICUM
inj., Roche) + fentanyl (0.02 mg/kg (FENTANYL, Janssen)
and medetomidine at the dose of 200 μg/kg (DOMITOR
inj. a.u.v., Pfizer). Total inhalation anaesthesia was then
maintained by a mixture of oxygen, nitrous oxide (2 : 3)
and isoflurane (FORANE, Abbott Laboratoires) using a
non re-breathing system (Bain). The heart rate, respiratory
rate, invasive blood pressure, end-tidal partial pressure of
carbon dioxide and saturation of haemoglobin by oxygen
was monitored (DATEX Cardiocap II). As this combina-
tion of drugs causes a strong respiratory depression, all
animals were connected and controlled by ventilation
device.
Rabbits were placed in dorsal recumbency and the surgical
site was routinely prepared for the aseptic procedure on
both knees. Lateral arthrotomy of the stifle joint was per-
formed by parapatellar incision. After visual localization
of the growth plate, the battery-powered drill (Colibri sys-
tem, SYNTHES, USA) was used to create a defect in the lat-
eral part of the distal femoral physis in order to cause
damage exceeding 9% of the growth plate area [5,13,14].
Therefore, a 3.5 mm drill bit (ACUFEX – MosaicPlasty Pre-
cision, Smith&Nephew, USA) was used to bore a canal 12
mm deep from the lateral surface of the lateral condyle
dorsolaterally above the insertion of m. extensor digito-
rum longus. The canal was drilled in the dorsomedialBMC Biotechnology 2008, 8:70 http://www.biomedcentral.com/1472-6750/8/70
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direction in order to cause damage of the lateral part of the
distal femoral physis including the adjacent parts of epi-
physis and metaphysis. The external part of the canal of
the iatrogenic defect of the distal physis of the right femur
was closed only with a cylinder made from beta-trical-
cium phosphate (ChronOS, SYNTHES) 3.5 mm thick and
2 mm long, that was cut out from a pre-formed ChronOS
block using a 3.5 mm tubular chisel (ACUFEX – Mosaic-
Plasty Precision, Smith&Nephew, USA). This bioceramic
cylinder was stained with methylene blue (ModR mety-
lenovA, ind., 100 g, FISHER SCIENTIFIC) for easier orien-
tation during the following arthrotomy with the bone
bridge excision and therapeutic transplantation of MSCs.
The stifle joint was lavaged with Ringer Lactat solution
(Ringer Lactat I.V.Inf., Braun Medical AG). The joint cap-
sule was closed with an interrupted suture (polypropyl-
ene, Prolene 4/0, Ethicon). The subcutaneous layer was
closed with a continuous suture using 2/0 polyglactin 910
(Vicryl, Ethicon). The skin was closed with a simple inter-
rupted suture using 2/0 polyglactin 910 (Vicryl, Ethicon).
This iatrogenically created defect of the distal physis of the
right femur in animals of Groups A and B then served as
the site of transplantation of the gel scaffold with autoge-
nous mesenchymal stem cells (Group A) or allogeneic
MSCs (Group B). The defect of the growth cartilage was
created using the same method in the left femoral bone
and was left in all the animals in groups A and B without
transplantation of MSCs and served in both groups as
control.
Three weeks after causing the damage we performed
arthrotomy of the right knee joint using the same method
in animals of both groups A and B. The bioceramic cylin-
der stained with methylene blue and the bone bridge
formed at the site of the original physeal defect were
bored off by a drill with a 3.5 mm diameter (SYNTHES).
Before transplantation of the scaffold with MSCs, the
canal was dilated using a 3.5 mm dilator (ACUFEX –
MosaicPlasty Precision, Smith&Nephew, USA). A mixture
of the scaffold and MSCs (autogenous in Group A; alloge-
neic in Group B, respectively) was prepared in wells of a
microtitration plate (TPT), from where the implant (in the
form of a cylinder 3.5 mm thick and 10 mm long) was
taken by the drill guide (ACUFEX – MosaicPlasty Preci-
sion, Smith&Nephew, USA) and carefully inserted using a
delivery tamp (ACUFEX – MosaicPlasty Precision,
Smith&Nephew, USA) into the defect drilled in the lateral
right femoral condyle. In order to fix the transplant in its
position, the canal was closed (on the lateral surface of the
lateral condyle of the femur) with a cylinder made from
beta-tricalcium phosphate (ChronOS, SYNTHES) 3.5 mm
thick and 2 mm long, that was cut out from a pre-formed
ChronOS block using a 3.5 mm tubular chisel (ACUFEX –
MosaicPlasty Precision, Smith&Nephew, USA).
Antagonization of all three anaesthetic components was
performed using a combination of naloxon (0.03 mg/kg)
(INTRENON inj., Leciva a.s.) + flumazenil (0.1 mg/kg)
(ANEXATE, Hoffmann-La Roche Ltd.) + atipamezol (1.0
mg/kg) (ANTISEDAN inj. ad us. vet., Pfizer Animal
Health) administered intramuscularly after the surgery.
Analgesia in the post-operative period was achieved by
administration of carprofen (RIMADYL inj. ad us. vet.,
Pfizer Animal Health) at the dose of 2 mg/kg/day for three
days after the surgery. The animals were allowed to walk
freely and bear weight as tolerated following recovery
from surgery. The animals were fed, handled and housed
according to the principles of welfare during the whole
study period. At the end of the experiment (4 months after
the first surgery), all animals were euthanized lege artis.
Firstly, they were put under general anaesthesia using
intravenous thiopental at the dose of 20 mg/kg; then they
were given intravenous T 61 inj. ad us. vet. (Hoechst Rous-
sel Vet.) at the dose of 1 ml pro toto.
The length and angular (valgus) deformity of the operated
bone were measured from radiographs in the craniocau-
dal (CC) projection. The quality of graft incorporation
was evaluated histologically. The presence of transplanted
cells in the physis was detected by immunofluorescence.
All procedures were conducted with the consent of the
Ethical Committee (No. 46613/2003-1020).
Bone length discrepancy and femoral valgus deformity 
measurements
Each rabbit was subjected to radiological examination on
the day of the first surgery (bone marrow blood harvest-
ing), and after euthanasia. Bone length discrepancy and
valgus deformity were measured from radiographs.
Length measurement of the right femur (with the physeal
defect and transplanted MSCs) and the left femur (with
the physeal defect without transplanted MSCs) was done
from radiographs of the femur in the craniocaudal (CC)
projection. Actual length of the femur and the angle of
valgus deformity of the distal femur were measured. The
measurements were performed separately by three inde-
pendent observers. The measured values were averaged to
calculate the arithmetic mean.
Magnetic resonance imaging
We used magnetic resonance imaging to in vivo detection
of transplanted MSCs in the physeal defect. The rabbits
were subjected to MRI examination three weeks after the
surgery and on the day of euthanasia – they were exam-
ined by the technique of T1 weighed images and by the
sequence modified to highlight the hyposignal of MSCs
labelled with iron oxide (detection of paramagnetic ironBMC Biotechnology 2008, 8:70 http://www.biomedcentral.com/1472-6750/8/70
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oxide nanoparticles, Resovist). A three-week interval
between the transplantation and the first MRI examina-
tion was allowed to eliminate possible formation of arti-
facts caused by postoperative haematoma [16].
Histological findings
The defect healing was examined histologically using hae-
matoxiline and eosin staining. Following the excision of
femurs of the euthanized rabbits, femoral distal epiphyses
were placed and stabilized in a 10% solution of formalin.
They were then decalcified and gradually dehydrated in
solutions with an increasing concentration of alcohol to
enable them take to paraffin. Ultrathin paraffin sections
of the distal femur 0.1 mm in thickness were stained with
haematoxiline and eosin (HE) and subjected to micros-
copy, histochemical analysis – collagen – 2 immunostain-
ing (Picture 4) and PAS reaction were provided. The defect
site in the growth plate of the femur was examined histo-
logically. The presence of the hyaline cartilage in the orig-
inal defect was observed, as well as possible histological
signs of transplant rejection (lymphocyte infiltrate, carti-
lage separation from the surrounding tissue, ligament
degeneration). The ferrous stain Resovist incorporated in
the MSC cytoplasma allowed the processing of one of the
histological sections for Pearls reaction (staining with Ber-
lin blue) and thus to verify the origin of chondrocytes
from the transplanted MSCs.
These examinations should prove whether the chondro-
cytes present in the defect originated from the implanted
colony of MSCs or not on the basis of immunofluores-
cence detection of the CM-DiI stain incorporated into the
cell wall.
Statistical evaluation
Means and standard deviations were calculated for the
length and valgus deformity of the right femur (with the
physeal defect and transplanted MSCs) and the left femur
(with the physeal defect without transplanted MSCs) as
well as for differences in length and angular deformities
before MSCs transplantation and after euthanasia. The
values were statistically analyzed using Wilcoxon
matched-pairs test; STATISTICA (data analysis software
system), version 7.1 (StatSoft, Inc. 2005).
Results
No animal suffered perioperative complications or pre-
mature death. During the cultivation of MSCs, two exper-
imental animals had to be transferred from Group A to
Group B, as their autogenous graft did not reach the
number of cells needed for a successful transplantation.
Four months after the transplantation, the right femurs of
animals of Group A (with the excised bone bridge and
transplanted autogenous MSCs) were longer on average
by 0.50 ± 0.04 cm (p = 0.018) than their left (control)
femurs (without transplanted MSCs). 4 months after the
transplantation the right femurs of rabbits of Group B
(with the excised bone bridge and transplanted allogeneic
MSCs) were longer on average by 0.43 ± 0.01 cm (p =
0.028) than their left (control) femurs (without trans-
planted MSCs).
4 months after the therapeutic transplantation of MSCs
was the valgus deformity of the distal part of the right
femur in the animals of Group A (with the excised bone
bridge and transplanted autogenous MSCs significantly
lower (by 4.45 ± 1.86°) than valgus deformity of the dis-
tal segment of their left (control) femur (without trans-
planted MSCs) (p = 0.028).
Likewise, valgus deformity of the distal part of the right
femur in the animals of Group B (with the excised bone
bridge and transplanted MSCs) was 4 months after the
therapeutic transplantation of MSCs significantly lower
(by 3.66 ± 0.95°) than valgus deformity of the distal seg-
ment of their left (control) femur (without transplanted
MSCs) (p = 0.001).
However, no statistically significant difference was found
in the length (i.e., the lengthwise growth) of the right fem-
oral bone (p = 0.495) and its valgus deformity (p =
0.1597) between rabbits with transplanted autogenous
MSCs (Group A) and rabbits with transplanted allogeneic
MSCs (Group B).
MRI examination proved the presence of paramagnetic
nano-particles of iron oxide at the site of transplantation
of labelled MSCs in the lateral section of the right femoral
condyle in 100% of cases 3 weeks after the transplantation
as well as 4 months after the transplantation (Fig. 1).
The presence of newly formed hyaline cartilage was con-
firmed by histological examination at the site of the orig-
inal defect of the growth plate of the right distal femur in
all the animals of both groups A and B (Fig. 2). No histo-
logical signs of allogeneic transplant rejection were found
in the microscopic sections of the distal physis of the right
femur (experimental animals of Group B with implanted
allogeneic MSCs). A bone bridge was histologically dem-
onstrated in all cases in the distal physis of the left femur
with an iatrogenic growth cartilage defect without trans-
planted MSCs (Fig. 2). Pearls reaction in the histological
preparation of the distal physis of the right femur of all the
animals of both groups A and B was positive. The presence
of particles of the lipophilic stain DiI was confirmed by
immunofluorescence in all the histological samples of the
distal growth zones of the right femoral bones with the
exception of one case in Group A (MSC autotransplanta-
tion) and one case in Group B (MSC allotransplantation)
(Fig. 3). Histochemical analysis – collagen – 2 immunos-BMC Biotechnology 2008, 8:70 http://www.biomedcentral.com/1472-6750/8/70
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taining (Fig 4) and PAS reaction was positive in all the his-
tological samples of the distal growth zones of the right
femoral bones in Group A and B.
Discussion
In our experimental study, we tried to find whether there
is difference in the results of a bone bridge treatment by
its excision and transplantation of mesenchymal stem
cells in dependence on the type of the cellular implant
used (autogenous vs. allogeneic MSCs). Thus, the funda-
mental question is whether we can expect the same clini-
cal results from autogenous and allogeneic
transplantation of MSCs.
It is appropriate to investigate both methods for future
clinical practice. Allografts may be potentially used in
both preventive and therapeutic transplantation into the
damaged growth plate. The bone bridge formation may
be detected approximately 4 weeks after injury by radio-
logical or CT examination or by magnetic resonance
[17,18]. If diagnosing a physeal closure by a bone bridge,
it would then be possible to use the cultivated autogenous
MSCs collected from the patient when the trauma origi-
nated. If the bone bridge, representing a risk of growth dis-
order of the injured bone (9% of the physeal area)
[5,13,14], did not form, it would be possible to keep the
unused cells in the tissue bank as a potential MSC
allotransplant.
The use of progenitors of chondrogenic differentiation,
i.e. stem cells of mesenchymal origin, started to present
itself immediately after the first promising experiments
with transplantation of autogenous/allogeneic chondro-
cytes [13,14]. Apart from the bone marrow the source of
MSCs may also be the synovial fluid, periosteum, adipose
tissue and partly also muscular tissue [8,19]. Their collec-
tion should not be burdensome for the potential donor or
the patient him/herself. To keep MSC allotransplants suc-
Resovist contrast agent incorporated into transplanted MSCs Figure 1
Resovist contrast agent incorporated into trans-
planted MSCs. The arrow shows an artifact created from 
paramagnetic iron nano-particles with Resovist contrast 
agent incorporated into transplanted MSCs (rabbit A5).
Histological examination of the distal femoral physis in rabbits after autogenous MSC transplantation (HE stain) Figure 2
Histological examination of the distal femoral physis in rabbits after autogenous MSC transplantation (HE 
stain). A – after autogenous MSC transplantation into the femoral defect (magnification × 40 – rabbit A10). B – after allogeneic 
MSC transplantation into the femoral defect (magnification × 100 – rabbit B3). C – left femur physeal defect without MSC 
transplantation – bone bridge was formed (magnification × 20 – rabbit B6 – left femur).BMC Biotechnology 2008, 8:70 http://www.biomedcentral.com/1472-6750/8/70
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cessfully in tissue and cell banks and to use them without
further delay in case of need in an acute injury of the
growth plate if the future shows that it is possible in exper-
iments and subsequently in clinical practice, the method
of treating physeal plate traumas by preventive transplan-
tation of MSCs would appear perspective [6]. A suitable
scaffold that would provide the cells not only with suffi-
cient space and mechanical support for growth but also
with an adequate supply of nutrients could be prepared
e.g. on the basis of IPN (Interpenetrating Polymer Net-
work). Rightly timed cascade of other factors that may
influence in vivo the intercellular matrix is needed apart
from the initiation of cell differentiation by supplement-
ing some recombinant factors. In the abovementioned
cytology laboratories, the differentiation scheme with the
use of TGF-β1 [15] was repeatedly effective in experi-
ments. In general, TGF-β1 and other members of TGF
superfamily (BMP2, BMP4) are used for chondrogenic dif-
ferentiation of MSC cells and TGF is the most „tradi-
tional”. Most strikingly BMP2 is also used in several
studies to promote chondrogenesis although it preferen-
tially stimulates osteogenesis. To our knowledge more
than growth factor used culture conditions are more imor-
tant for targeted differentiation. As chondrogenesis and
osteogenesis display similar initiation processes (nodule
formation and collagen deposition) related molecules
sucg as TGF and BMP can substitute each other. Our in
vitro observations and published articles by other authors
indicate that osteogenesis takes place mainly in confluent-
like 2D culture while chondrogenesis requires high cell
density 3D culture and reduction of cell adhesion to rigid
surface. Other supplements in differentiation media (dex-
amethasone and ascorbic acid) are stimulatory for colla-
gen biosynthesis without any direct effect to
differentiation signalling.
The surgical procedure and method of creating the iatro-
genic defect in the growth cartilage was chosen in this
study on the basis of good experience with methodology
used in our previous experiments [6,7,13,14] and in sim-
ilar studies of other authors [9,20].
These rabbits attain full femoral maturity at approxi-
mately 4 – 6 months of age [9,20,21], our observation
period (5 week by the operation, 4 months observation
period) consists with this reality. The iatrogenic damage
of the growth cartilage and in order to make the biggish
defect (7 – 9% of growth plate area) described Janarv [5].
Radiological examination is easily accessible and allows
determining with a relatively high accuracy both the
length of the x-rayed bone and its possible angular
deformity. The method of measuring the femoral bone
length in the rabbit was based on Janarv's original study
[5], whereas the measuring of the extent of valgus deform-
ity had been consulted with specialists on descriptive
geometry previously for the needs of earlier studies of the
authors [6,7].
The detection of paramagnetic iron nanoparticles of the
phagocyted MSCs in the preparatory phase in vitro using
MRI is very favourable. In live animals it allows us to
detect, i.e. before the end of the experiment, their presence
at the site of transplantation, or to find their extinction or
travel from the destination site, etc.
Immunofluorescence stain DiI in chondrocyte membranes  (arrows) differentiated from implanted allogeneic MSCs (rab- bit A5 × 400) Figure 3
Immunofluorescence stain DiI in chondrocyte mem-
branes (arrows) differentiated from implanted allo-
geneic MSCs (rabbit A5× 400).
Histochemical analysis – collagen – 2 immunostaining  (arrows), positive result (rabbit A2 × 100) Figure 4
Histochemical analysis – collagen – 2 immunostaining 
(arrows), positive result (rabbit A2 × 100).BMC Biotechnology 2008, 8:70 http://www.biomedcentral.com/1472-6750/8/70
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Histological examination of microsections stained with
haematoxiline and eosin (HE) gives a reliable answer to
the character and quality of the cartilage in the iatrogeni-
cally created defects. The results of our examinations were
fully in accordance with the established hypothesis and
also corresponded with the results of several similar stud-
ies [9,20]. The presence of bright blue granules in the
chondrocyte cytoplasma (Resovist combined with Berlin
blue – Pearls reaction) and immunofluorescence stain
CM-DiI [9] reliably determined the origin of the cells from
the MSC transplant used by out team.
The results of our work indicate that the transplantation
of mesenchymal stem cells into the physis at the site of the
excised bone bridge may prevent the shortening of the
affected bone and the occurrence of angular deformities.
At the same time, the study confirmed in an animal model
that there is no qualitative difference (hyaline cartilage) in
the character of the newly formed cartilaginous tissue in
the use of autogenous vs. allogeneic MSCs. In clinical use,
both methods of MSC transplantation (auto- and
allotransplantation) may have their justification, in
dependence on the given clinical case and circumstances
of treatment.
Conclusion
Allogeneic as well as autogenous transplantations of
MSCs into the growth zone defect after the bone bridge
excision prevented limitation of the bone growth length-
wise and prevented the development of its angular
deformity. Concurrently, no difference was found
between the results of allogeneic and autogenous trans-
plantation of MSCs. Both from the viewpoint of the
lengthwise bone growth and its potential angular deform-
ity. From the viewpoint of the quality of the newly formed
cartilaginous tissue at the site of the original physeal
defect. Following autogenous as well as allogeneic trans-
plantations of MSC, the presence of hyaline cartilage was
histologically confirmed at the site of the treated growth
plate defect. In the case of allotransplants, no histological
signs of their rejection were found. At the same time it was
demonstrated in vivo and in vitro that the chondrocytes
newly formed at the site of the physeal defect originated
from the transplanted mesenchymal stem cells.
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